CJ OliveNetworks said on Tuesday it will build an AX leading-model AI factory at WiseMedi's Jincheon Plant 2, a producer of intravenous solutions and a unit of Yuhan, through the Ministry of SMEs and Startups' "mutual-growth AX leading model build support project."
The company said the project focuses on providing AX conversion technology and build experience so small and medium-sized and mid-sized manufacturers with production capabilities can speed up AI and data-based manufacturing innovation.
CJ OliveNetworks will apply AI and data technologies to WiseMedi's existing manufacturing infrastructure to make quality inspection and equipment management more intelligent. It will also implement a pharmaceutical-focused AX system to improve the reliability and traceability of process and quality data.
It will especially step up the use of AI in quality inspection. It will add AI vision inspection to the existing system to check the packaging condition of all intravenous-solution products and support screening out items with uneven or folded sealing areas.
Inspection results will be linked to robots so products judged defective are not stacked. CJ OliveNetworks plans to secure AI detection performance of at least 95 percent to improve accuracy and consistency. It will also apply AI-based predictive maintenance to equipment management to detect abnormal signs early and set up a system for proactive maintenance based on equipment condition.
WiseMedi said it expects the project to help it establish a manufacturing foundation to systematically meet global-level GMP requirements, including data integrity.
Won-cheol Song (송원철), head of smart logistics and factory at CJ OliveNetworks, said the project is a leading case of applying AI and data technologies to pharmaceutical manufacturing sites that require a high level of quality control and data reliability. Based on technologies verified in the field and build experience, he said the company will accelerate AX conversion in pharmaceutical manufacturing and support strengthening customers' manufacturing competitiveness.